- Home
- TIL vs PSNL Comparison
TIL vs PSNL Comparison
Compare TIL & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- PSNL
- Stock Information
- Founded
- TIL 2018
- PSNL 2011
- Country
- TIL United States
- PSNL United States
- Employees
- TIL N/A
- PSNL N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- PSNL Medical Specialities
- Sector
- TIL Health Care
- PSNL Health Care
- Exchange
- TIL Nasdaq
- PSNL Nasdaq
- Market Cap
- TIL 177.1M
- PSNL 518.8M
- IPO Year
- TIL 2021
- PSNL 2019
- Fundamental
- Price
- TIL $18.94
- PSNL $9.44
- Analyst Decision
- TIL Strong Buy
- PSNL Strong Buy
- Analyst Count
- TIL 5
- PSNL 5
- Target Price
- TIL $100.67
- PSNL $8.70
- AVG Volume (30 Days)
- TIL 109.9K
- PSNL 1.3M
- Earning Date
- TIL 11-12-2025
- PSNL 11-04-2025
- Dividend Yield
- TIL N/A
- PSNL N/A
- EPS Growth
- TIL N/A
- PSNL N/A
- EPS
- TIL N/A
- PSNL N/A
- Revenue
- TIL N/A
- PSNL $80,317,000.00
- Revenue This Year
- TIL N/A
- PSNL N/A
- Revenue Next Year
- TIL N/A
- PSNL $29.83
- P/E Ratio
- TIL N/A
- PSNL N/A
- Revenue Growth
- TIL N/A
- PSNL 0.36
- 52 Week Low
- TIL $10.80
- PSNL $2.83
- 52 Week High
- TIL $44.50
- PSNL $10.95
- Technical
- Relative Strength Index (RSI)
- TIL 45.86
- PSNL 62.69
- Support Level
- TIL $18.10
- PSNL $8.53
- Resistance Level
- TIL $20.32
- PSNL $10.95
- Average True Range (ATR)
- TIL 1.56
- PSNL 0.91
- MACD
- TIL 0.20
- PSNL 0.05
- Stochastic Oscillator
- TIL 37.96
- PSNL 57.54
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.